memantine has been researched along with Ischemia in 7 studies
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It has been reported that memantine, a drug for Alzheimer's disease has anti-oxidative role against cerebral ischemic stroke and cardiac ischemia reperfusion." | 8.02 | Beneficial effects of memantine on ischemia/reperfusion injury following torsion/detorsion induced testicular damage in rats: Improvement in histological and biochemical parameters. ( Ghasemnejad-Berenji, H; Ghasemnejad-Berenji, M; Jafari, A; Nemati, M; Pashapour, S; Sadeghpour, S, 2021) |
| "Retinal ischemia increased vitreous concentrations of glutamate and glycine." | 7.70 | Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. ( Bach, M; Feuerstein, TJ; Knörle, R; Lagrèze, WA, 1998) |
| "Memantine was also able to block long-term potentiation recorded from spiny neurons following a brief ischemic episode." | 5.34 | Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. ( Belcastro, V; Calabresi, P; Costa, C; Di Filippo, M; Parnetti, L; Picconi, B; Siliquini, S; Tantucci, M; Tozzi, A, 2007) |
| " It has been reported that memantine, a drug for Alzheimer's disease has anti-oxidative role against cerebral ischemic stroke and cardiac ischemia reperfusion." | 4.02 | Beneficial effects of memantine on ischemia/reperfusion injury following torsion/detorsion induced testicular damage in rats: Improvement in histological and biochemical parameters. ( Ghasemnejad-Berenji, H; Ghasemnejad-Berenji, M; Jafari, A; Nemati, M; Pashapour, S; Sadeghpour, S, 2021) |
| "Retinal ischemia increased vitreous concentrations of glutamate and glycine." | 3.70 | Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. ( Bach, M; Feuerstein, TJ; Knörle, R; Lagrèze, WA, 1998) |
| "In the memantine group 47% of the neurons survived ischemia, in the cerestat group 61%, and in the riluzole group 43%." | 3.70 | [Neuroprotection in ischemia of the retina in an animal model]. ( Feuerstein, TJ; Lagrèze, WA; Otto, T, 1999) |
| "S-memantine was synthesized by chemically combining a slow releasing H(2)S donor 4-(3-thioxo-3H-1,2-dithiol-4-yl)-benzoic acid (ACS48) with a NMDAR antagonist memantine." | 1.38 | A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death. ( Arai, K; Atochin, DN; Ichinose, F; Khatri, A; Kida, K; Kosugi, S; Marutani, E; Nguyen, R; Tokuda, K; Van Leyen, K, 2012) |
| "Memantine was also able to block long-term potentiation recorded from spiny neurons following a brief ischemic episode." | 1.34 | Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. ( Belcastro, V; Calabresi, P; Costa, C; Di Filippo, M; Parnetti, L; Picconi, B; Siliquini, S; Tantucci, M; Tozzi, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Jafari, A | 1 |
| Ghasemnejad-Berenji, H | 1 |
| Nemati, M | 1 |
| Pashapour, S | 1 |
| Sadeghpour, S | 1 |
| Ghasemnejad-Berenji, M | 1 |
| Marutani, E | 1 |
| Kosugi, S | 1 |
| Tokuda, K | 1 |
| Khatri, A | 1 |
| Nguyen, R | 1 |
| Atochin, DN | 1 |
| Kida, K | 1 |
| Van Leyen, K | 1 |
| Arai, K | 1 |
| Ichinose, F | 1 |
| Tozzi, A | 1 |
| Costa, C | 1 |
| Di Filippo, M | 1 |
| Tantucci, M | 1 |
| Siliquini, S | 1 |
| Belcastro, V | 1 |
| Parnetti, L | 1 |
| Picconi, B | 1 |
| Calabresi, P | 1 |
| Osborne, NN | 1 |
| Herrera, AJ | 1 |
| Vogels, BA | 1 |
| Maas, MA | 1 |
| Daalhuisen, J | 1 |
| Quack, G | 1 |
| Chamuleau, RA | 1 |
| Lagrèze, WA | 2 |
| Knörle, R | 1 |
| Bach, M | 1 |
| Feuerstein, TJ | 2 |
| Otto, T | 1 |
7 other studies available for memantine and Ischemia
| Article | Year |
|---|---|
Beneficial effects of memantine on ischemia/reperfusion injury following torsion/detorsion induced testicular damage in rats: Improvement in histological and biochemical parameters.
Topics: Animals; Humans; Ischemia; Male; Malondialdehyde; Memantine; Rats; Reperfusion Injury; Spermatic Cor | 2021 |
A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death.
Topics: Animals; Brain Injuries; Brain Ischemia; Cell Death; Cell Line, Tumor; Cells, Cultured; Drug Design; | 2012 |
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid.
Topics: Animals; Brain; Convulsants; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulati | 2007 |
The effect of experimental ischaemia and excitatory amino acid agonists on the GABA and serotonin immunoreactivities in the rabbit retina.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amin | 1994 |
Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.
Topics: Ammonia; Animals; Body Water; Brain; Disease Models, Animal; Electroencephalography; Glutamic Acid; | 1997 |
Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia.
Topics: Animals; Cell Count; Chromatography, High Pressure Liquid; Disease Models, Animal; Excitatory Amino | 1998 |
[Neuroprotection in ischemia of the retina in an animal model].
Topics: Animals; Intraocular Pressure; Ischemia; Male; Memantine; Neuroprotective Agents; Rats; Rats, Spragu | 1999 |